AAPL   322.12 (+1.26%)
MSFT   183.49 (+0.92%)
FB   228.85 (-0.13%)
AMZN   2,423.00 (+0.52%)
NVDA   345.68 (+1.37%)
BABA   202.01 (+0.41%)
MU   47.51 (-3.92%)
GE   6.85 (-6.17%)
TSLA   817.49 (-0.33%)
ACB   15.56 (+1.70%)
F   5.92 (-1.99%)
NFLX   418.03 (-0.44%)
AAPL   322.12 (+1.26%)
MSFT   183.49 (+0.92%)
FB   228.85 (-0.13%)
AMZN   2,423.00 (+0.52%)
NVDA   345.68 (+1.37%)
BABA   202.01 (+0.41%)
MU   47.51 (-3.92%)
GE   6.85 (-6.17%)
TSLA   817.49 (-0.33%)
ACB   15.56 (+1.70%)
F   5.92 (-1.99%)
NFLX   418.03 (-0.44%)
AAPL   322.12 (+1.26%)
MSFT   183.49 (+0.92%)
FB   228.85 (-0.13%)
AMZN   2,423.00 (+0.52%)
NVDA   345.68 (+1.37%)
BABA   202.01 (+0.41%)
MU   47.51 (-3.92%)
GE   6.85 (-6.17%)
TSLA   817.49 (-0.33%)
ACB   15.56 (+1.70%)
F   5.92 (-1.99%)
NFLX   418.03 (-0.44%)
AAPL   322.12 (+1.26%)
MSFT   183.49 (+0.92%)
FB   228.85 (-0.13%)
AMZN   2,423.00 (+0.52%)
NVDA   345.68 (+1.37%)
BABA   202.01 (+0.41%)
MU   47.51 (-3.92%)
GE   6.85 (-6.17%)
TSLA   817.49 (-0.33%)
ACB   15.56 (+1.70%)
F   5.92 (-1.99%)
NFLX   418.03 (-0.44%)
Log in

NASDAQ:DRNADicerna Pharmaceuticals Earnings Date, Estimates & History

$21.25
+0.86 (+4.22 %)
(As of 05/28/2020 02:46 PM ET)
Add
Compare
Today's Range
$20.25
Now: $21.25▼
$21.71
50-Day Range
$18.10
MA: $21.29▼
$24.35
52-Week Range
$11.75
Now: $21.25▼
$27.68
Volume25,400 shs
Average Volume621,838 shs
Market Capitalization$1.57 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.84

Earnings

Dicerna Pharmaceuticals (NASDAQ:DRNA) Earnings Information

Dicerna Pharmaceuticals last announced its quarterly earnings results on May 7th, 2020. The biopharmaceutical company reported ($0.31) EPS for the quarter, missing analysts' consensus estimates of $0.28 by $0.59. The company earned $34.03 million during the quarter, compared to analyst estimates of $59.61 million. Dicerna Pharmaceuticals has generated ($1.76) earnings per share over the last year. Dicerna Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Dicerna Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Dicerna Pharmaceuticals (NASDAQ:DRNA) Earnings Estimates

2020 EPS Consensus Estimate: $1.31
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203$0.25$0.59$0.37
Q2 20203($0.10)$0.59$0.25
Q3 20203($0.11)$0.65$0.37
Q4 20203($0.05)$0.58$0.32

Dicerna Pharmaceuticals (NASDAQ DRNA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/13/2020
(Estimated)		       
5/7/20203/31/2020$0.28($0.31)($0.31)$59.61 million$34.03 millionTranscript
2/27/202012/31/2019($0.08)($0.58)($0.58)$26.40 million$7.08 millionTranscript
11/7/2019Q3($0.30)($0.45)($0.45)$11.70 million$8.04 millionListen
8/8/2019Q2 2019($0.32)($0.35)($0.35)$10.95 million$5.68 millionTranscript
5/9/20193/31/2019($0.22)($0.38)($0.38)$10.59 million$3.11 millionN/A
3/11/201912/31/2018($0.23)($0.29)($0.29)$8.38 million$1.54 millionTranscript
11/5/20189/30/2018($0.24)($0.35)($0.35)$1.67 million$1.55 millionTranscript
8/8/2018Q2 2018($0.42)($0.68)$0.12$1.79 million$1.55 millionN/A
5/14/2018Q1 2018($0.87)($0.30)($0.30)$1.75 million$1.55 millionTranscript
3/8/2018Q4 2017($0.65)($0.90)($0.90)$1.45 million$1.40 millionTranscript
11/2/2017Q3 2017($0.70)($0.92)($0.92)$0.47 millionN/A
8/10/2017Q2 2017($0.61)($1.15)($1.15)$0.08 million$0.25 millionN/A
5/8/2017Q1 2017($0.65)($0.68)($0.68)$0.08 million$0.13 millionListen
3/30/2017Q4 2016($0.73)($0.68)($0.68)$0.13 millionN/A
11/7/2016Q316($0.87)($0.68)($0.68)$162.00 millionListen
8/4/2016Q216($0.84)($0.75)($0.75)N/A
5/9/2016Q116($0.86)($0.76)($0.76)N/A
3/10/2016Q415($0.84)($0.76)($0.76)$2.50 millionListen
11/10/2015Q315($0.84)($0.82)($0.82)Listen
8/6/2015Q215($0.78)($0.86)($0.86)$0.18 millionN/A
5/11/2015Q1($0.7270)($0.79)($0.79)$600.00 millionListen
3/12/2015Q414($0.57)($0.63)($0.44)$1.45 millionN/A
11/6/2014Q3 2014($0.63)($0.63)($0.63)N/A
8/7/2014Q2 2014($0.42)($0.64)($0.64)N/A
5/13/2014Q114($0.52)($0.76)($0.50)Transcript
3/27/2014Q4 2013($0.20)($0.20)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/28/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.